McKesson Corporation is a leading healthcare services and information technology company that specializes in the distribution of pharmaceuticals and medical supplies. The company provides a comprehensive range of services that enhance the efficiency of healthcare systems, including drug distribution to pharmacies, hospitals, and other healthcare providers. Additionally, McKesson offers innovative solutions for managing medical costs, optimizing inventory, and improving patient care through data analytics and technology. By ensuring the timely delivery of critical medical products and services, McKesson plays a vital role in the healthcare ecosystem, supporting both providers and patients. Read More
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
McKesson Corp exemplifies GARP investing, offering strong earnings growth at a reasonable valuation, backed by solid profitability and financial strength.
Free cash flow is one of the most reliable indicators of financial durability.
These businesses not only generate cash but reinvest intelligently to sustain momentum.
New York, NY – December 1, 2025 – U.S. Treasury yields have experienced a significant climb today, marking a pivotal moment for financial markets. This ascent, driven by a complex interplay of global monetary policy shifts, persistent inflation concerns, and the ever-growing specter of increased government borrowing, has sent immediate ripple
Each stock in this article is trading near its 52-week high.
These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare providers & services stocks fared in Q3, starting with McKesson (NYSE:MCK).
Healthcare distributor and services company McKesson (NYSE:MCK) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 10.1% year on year to $103.2 billion. Its non-GAAP profit of $9.86 per share was 8.9% above analysts’ consensus estimates.
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
McKesson Corporation (NYSE: MCK) has released its fiscal 2026 second quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be nearing another interest rate cut.
Healthcare distributor and services company McKesson (NYSE:MCK)
will be reporting earnings this Wednesday afternoon. Here’s what investors should know.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 82 cents per share of common stock. The dividend will be payable on January 2, 2026 to shareholders of record on December 1, 2025.
